Azra Raza

20.5k total citations · 5 hit papers
278 papers, 12.3k citations indexed

About

Azra Raza is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Azra Raza has authored 278 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 220 papers in Hematology, 98 papers in Molecular Biology and 76 papers in Genetics. Recurrent topics in Azra Raza's work include Acute Myeloid Leukemia Research (206 papers), Chronic Myeloid Leukemia Treatments (46 papers) and Acute Lymphoblastic Leukemia research (43 papers). Azra Raza is often cited by papers focused on Acute Myeloid Leukemia Research (206 papers), Chronic Myeloid Leukemia Treatments (46 papers) and Acute Lymphoblastic Leukemia research (43 papers). Azra Raza collaborates with scholars based in United States, Canada and France. Azra Raza's co-authors include Naomi Galili, Benjamin L. Ebert, Hagop M. Kantarjian, Harvey D. Preisler, John M. Bennett, Alan F. List, Guillermo Garcia‐Manero, Kristen E. Stevenson, Omar Abdel‐Wahab and Rafael Bejar and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Azra Raza

271 papers receiving 12.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Decitabine improves patient outcomes in myelodysplastic syndromes

2006 1.1k citations Hagop M. Kantarjian, John M. Bennett et al. profile →
Clinical Effect of Point Mutations in Myelodysplastic Syndromes

2011 1.1k citations Rafael Bejar, Kristen E. Stevenson et al. New England Journal of Medicine profile →
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion

2006 893 citations Alan F. List, Gordon W. Dewald et al. New England Journal of Medicine profile →
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

2008 629 citations Benjamin L. Ebert, Jennifer Pretz et al. profile →
Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts

2014 398 citations Naomi Galili, Siddhartha Mukherjee et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Azra Raza United States	50	8.8k	5.5k	3.6k	1.6k	1.4k	278	12.3k
Eva Hellström‐Lindberg Sweden	40	8.2k 0.9×	4.0k 0.7×	3.8k 1.1×	1.2k 0.7×	1.4k 1.0×	187	10.6k
Peter L. Greenberg United States	45	9.1k 1.0×	3.2k 0.6×	3.8k 1.1×	1.7k 1.1×	1.4k 1.0×	203	11.0k
Ghulam J. Mufti United Kingdom	55	7.7k 0.9×	4.0k 0.7×	2.9k 0.8×	1.8k 1.1×	1.3k 0.9×	268	11.2k
Claudia Schoch Germany	56	8.9k 1.0×	5.1k 0.9×	3.4k 1.0×	1.3k 0.8×	2.9k 2.0×	194	11.4k
Aristoteles Giagounidis Germany	49	8.5k 1.0×	3.4k 0.6×	3.7k 1.0×	1.2k 0.8×	1.5k 1.0×	259	10.3k
Claude Preudhomme France	62	9.4k 1.1×	5.7k 1.0×	4.4k 1.2×	2.4k 1.5×	2.4k 1.7×	356	13.3k
Uwe Platzbecker Germany	54	8.8k 1.0×	3.6k 0.6×	4.1k 1.1×	1.7k 1.1×	1.6k 1.1×	543	11.3k
David Grimwade United Kingdom	50	12.7k 1.4×	8.4k 1.5×	3.0k 0.8×	1.8k 1.1×	4.5k 3.1×	152	15.6k
Marilyn L. Slovak United States	46	6.9k 0.8×	4.4k 0.8×	2.3k 0.6×	4.0k 2.5×	2.8k 1.9×	152	11.7k
Cristina Mecucci Italy	47	5.7k 0.6×	4.1k 0.8×	2.5k 0.7×	1.5k 1.0×	1.8k 1.3×	265	9.5k

Countries citing papers authored by Azra Raza

Since Specialization

Citations

This map shows the geographic impact of Azra Raza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azra Raza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azra Raza more than expected).

Fields of papers citing papers by Azra Raza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azra Raza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azra Raza. The network helps show where Azra Raza may publish in the future.

Co-authorship network of co-authors of Azra Raza

This figure shows the co-authorship network connecting the top 25 collaborators of Azra Raza. A scholar is included among the top collaborators of Azra Raza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azra Raza. Azra Raza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ali, Abdullah Mahmood & Azra Raza. (2024). scRNAseq and High-Throughput Spatial Analysis of Tumor and Normal Microenvironment in Solid Tumors Reveal a Possible Origin of Circulating Tumor Hybrid Cells. Cancers. 16(7). 1444–1444. 4 indexed citations

Galán-Díez, Marta, Abdullah Mahmood Ali, Álvaro Cuesta‐Domínguez, et al.. (2023). Serum Amyloid A1 (SAA1) Secreted By the Stromal Microenvironment Drives Malignant Clonal Proliferation in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML). Blood. 142(Supplement 1). 4118–4118.

Lieu, Yen K., Zhaoqi Liu, Abdullah Mahmood Ali, et al.. (2021). SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes. Proceedings of the National Academy of Sciences. 119(1). 36 indexed citations

Borot, Florence, et al.. (2019). Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies. Proceedings of the National Academy of Sciences. 116(24). 11978–11987. 92 indexed citations

Gualberto, Antonio, Catherine Scholz, Matthew R. Janes, Linda Kessler, & Azra Raza. (2017). The CXCL12/CXCR4 Pathway As a Potential Target of Tipifarnib in Acute Myeloid Leukemia and Myelodysplastic Syndromes. Blood. 130. 3957. 4 indexed citations

Zhang, Jian, Yen K. Lieu, Abdullah Mahmood Ali, et al.. (2015). Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities. Proceedings of the National Academy of Sciences. 112(34). E4726–34. 150 indexed citations

Bejar, Rafael, Kristen E. Stevenson, Bennett Adam Caughey, et al.. (2012). Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes. Journal of Clinical Oncology. 30(27). 3376–3382. 312 indexed citations

Galili, Naomi & Azra Raza. (2010). Pharmacotherapy of myelodysplastic syndromes. Expert Opinion on Pharmacotherapy. 11(11). 1889–1899. 2 indexed citations

Zaidi, Sayyed K., André J. van Wijnen, Jane B. Lian, et al.. (2009). Altered Runx1 Subnuclear Targeting Enhances Myeloid Cell Proliferation and Blocks Differentiation by Activating a miR-24/MKP-7/MAPK Network. Cancer Research. 69(21). 8249–8255. 92 indexed citations

10.

Ebert, Benjamin L., Naomi Galili, Pablo Tamayo, et al.. (2008). An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome. PLoS Medicine. 5(2). e35–e35. 111 indexed citations

11.

Markus, Ján, Juraj Bies, Naomi Galili, et al.. (2007). Methylation-Independent Silencing of the Tumor Suppressor INK4b (p15) by CBFβ-SMMHC in Acute Myelogenous Leukemia with inv(16). Cancer Research. 67(3). 992–1000. 17 indexed citations

12.

Černý, Jan, et al.. (2006). Low incidence of JAK2 and FLT3 mutations in patients with chronic myelomonocytic leukemia (CMML). Cancer Research. 66. 305–305. 1 indexed citations

13.

List, Alan F., Gordon W. Dewald, John M. Bennett, et al.. (2006). Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion. New England Journal of Medicine. 355(14). 1456–1465. 893 indexed citations breakdown →

14.

Saberwal, Gurveen, İmke Janssen, Vilasini Shetty, et al.. (2003). Involvement of Cyclin D1 and E2F1 in Intramedullary Apoptosis in Myelodysplastic Syndromes. Journal of Hematotherapy & Stem Cell Research. 12(4). 443–450. 11 indexed citations

15.

Raza, Azra & Suneel Mundle. (2001). Myelodysplastic syndromes & secondary acute myelogenous leukemia : directions for the new millennium. 4 indexed citations

16.

Ali, Ambereen, Suneel Mundle, Vilasini Shetty, et al.. (1999). Sequential Activation of Caspase-1 and Caspase-3-like Proteases During Apoptosis in Myelodysplastic Syndromes. Journal of Hematotherapy & Stem Cell Research. 8(4). 343–356. 28 indexed citations

17.

Shetty, Vilasini, Suneel Mundle, Jerome Loew, et al.. (1995). A Multivariate Study of Non Hodgkin's Lymphoma Involving Proliferation, Apoptosis, bcl-2 and the Microenvironment. Leukemia & lymphoma. 18(3-4). 273–279. 5 indexed citations

18.

Raza, Azra, Harvey D. Preisler, George P. Browman, et al.. (1993). Long Term Outcome of Patients with Acute Myelogenous Leukemia: The Role of Maintenance Therapy, Consolidation Therapy and the Predictive Value of Twoin vitroAssays. Leukemia & lymphoma. 10(1-2). 57–66. 2 indexed citations

19.

Raza, Azra, et al.. (1989). Detection of BrdU in the regenerating bone marrow cells of a patient with AML. Leukemia Research. 13(12). 1055–1059. 3 indexed citations

20.

Raza, Azra, et al.. (1987). Proliferative Characteristics of Acute Nonlymphocytic Leukemia in vivo. Acta Haematologica. 77(3). 140–145. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact